May 7, 2020 / 10:36 PM / 20 days ago

BRIEF-Merrimack Reports First Quarter 2020 Financial Results

May 7 (Reuters) - Merrimack Pharmaceuticals Inc:

* Q1 EARNINGS PER SHARE $0.02

* AS OF MARCH 31, HAD CASH AND CASH EQUIVALENTS AND INVESTMENTS OF $18.0 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below